The Prostate

Cover image for The Prostate

1 June 2007

Volume 67, Issue 8

Pages 799–906

  1. Original Articles

    1. Top of page
    2. Original Articles
    1. Effects of steroidal and non-steroidal antiandrogens on wild-type and mutant androgen receptors (pages 799–807)

      Masayasu Urushibara, Junichiro Ishioka, Nobuhiko Hyochi, Kazunori Kihara, Shuntaro Hara, Pratap Singh, John T. Isaacs and Yukio Kageyama

      Version of Record online: 20 MAR 2007 | DOI: 10.1002/pros.20542

    2. Characterization of the RSL1-dependent conditional expression system in LNCaP prostate cancer cells and development of a single vector format (pages 808–819)

      Julie Lessard, Sonia ben Aicha, Andréa Fournier, Ezequiel Calvo, Éliane Lavergne, Mélissa Pelletier and Claude Labrie

      Version of Record online: 20 MAR 2007 | DOI: 10.1002/pros.20559

    3. Mutational analysis of SPANX genes in families with X-Linked prostate cancer (pages 820–828)

      Natalay Kouprina, Vladimir N. Noskov, Greg Solomon, John Otstot, William Isaacs, Jianfeng Xu, Johanna Schleutker and Vladimir Larionov

      Version of Record online: 20 MAR 2007 | DOI: 10.1002/pros.20561

    4. A small chimeric promoter for high prostate-specific transgene expression from adenoviral vectors (pages 829–839)

      Robert Kraaij, Laura van der Weel, Corrina M.A. de Ridder, Hetty A.G.M. van der Korput, Joke L.M. Zweistra, Angélique L.C.T. van Rijswijk, Chris H. Bangma and Jan Trapman

      Version of Record online: 29 MAR 2007 | DOI: 10.1002/pros.20560

    5. Prostate-specific antigen stimulates osteoprotegerin production and inhibits receptor activator of nuclear factor-KappaB ligand expression by human osteoblasts (pages 840–848)

      Hiroyuki Yonou, Yutaka Horiguchi, Yoshio Ohno, Kazunori Namiki, Kunihiko Yoshioka, Makoto Ohori, Tadashi Hatano and Masaaki Tachibana

      Version of Record online: 29 MAR 2007 | DOI: 10.1002/pros.20574

    6. RNASEL Arg462Gln polymorphism and prostate cancer in PLCO (pages 849–854)

      Sarah E. Daugherty, Richard B. Hayes, Meredith Yeager, Gerald L. Andriole, Nilanjan Chatterjee, Wen-Yi Huang, William B. Isaacs and Elizabeth A. Platz

      Version of Record online: 3 APR 2007 | DOI: 10.1002/pros.20537

    7. Nanoparticulate delivery of suicide DNA to murine prostate and prostate tumors (pages 855–862)

      Weidan Peng, Daniel G. Anderson, Yunhua Bao, Robert F. Padera Jr., Robert Langer and Janet A. Sawicki

      Version of Record online: 10 APR 2007 | DOI: 10.1002/pros.20576

    8. Modulating testosterone stimulated prostate growth by phenethyl isothiocyanate via Sp1 and androgen receptor down-regulation (pages 863–870)

      Anastasia A. Beklemisheva, Jingyang Feng, Yunshin Albert Yeh, L. G. Wang and J. W. Chiao

      Version of Record online: 12 APR 2007 | DOI: 10.1002/pros.20472

    9. ErbB-4 may control behavior of prostate cancer cells and serve as a target for molecular therapy (pages 871–880)

      Rami Ben-Yosef, Alex Starr, Victoria Karaush, Vered Loew, Shahar Lev-Ari, Itay Barnea, Ghalib Lidawi, Alexander Shtabsky, Yoel Greif, Yosef Yarden and Akiva Vexler

      Version of Record online: 17 APR 2007 | DOI: 10.1002/pros.20555

    10. Molecular PCA3 diagnostics on prostatic fluid (pages 881–887)

      Martijn P.M.Q. van Gils, Erik B. Cornel, Daphne Hessels, W. Pim Peelen, J. Alfred Witjes, Peter F.A. Mulders, Harry G. Rittenhouse and Jack A. Schalken

      Version of Record online: 17 APR 2007 | DOI: 10.1002/pros.20564

    11. Urodynamic changes in a noble rat model for nonbacterial prostatic inflammation (pages 888–899)

      Jenni Bernoulli, Emrah Yatkin, Eva-Maria Talvitie, Risto Santti and Tomi Streng

      Version of Record online: 17 APR 2007 | DOI: 10.1002/pros.20567

    12. Analysis of the MDM2 antagonist nutlin-3 in human prostate cancer cells (pages 900–906)

      Ian R. Logan, Hesta V. McNeill, Susan Cook, Xiaohong Lu, John Lunec and Craig N. Robson

      Version of Record online: 17 APR 2007 | DOI: 10.1002/pros.20568